| Accession Number: | 0001192482-21-000555 |
| Date: | 2021-06-14 |
| Issuer: | RECRO PHARMA, INC. (REPH) |
| Original Submission Date: |
PARKS LAURA L.
C/O RECRO PHARMA, INC.
1 E. UWCHLAN AVE, SUITE 112
EXTON, PA 19341
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 2.23 | 2021-06-14 | deemed execution date | A | 20,000 (a) | 2031-06-14 | common stock 20,000 | $2.23 | 20,000 | direct |
| ID | footnote |
|---|---|
| f1 | the option will vest in three equal annual installments, beginning on june 14, 2022, subject to the reporting person's continuous service with the company. |
